← Open Payments lookup

CHARISSE MAGSAYSAY: Open Payments

NPI 1568061117 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,195 in 164 payments from 49 companies in 2025. Trend: 2023 $1,352 · 2024 $5,448 · 2025 $4,195

Food & beverage: $3,561Education: $535Long term medical supply or device loan: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation21$435
AstraZeneca Pharmaceuticals LP9$350
SOBI, INC6$300
Janssen Biotech, Inc.12$269
Astellas Pharma US Inc5$221
Celgene Corporation12$209
Gilead Sciences, Inc.4$202
Bayer Healthcare Pharmaceuticals Inc.7$180
Eisai Inc.6$134
PFIZER INC.7$134

Products named: KISQALI, Nubeqa, ERLEADA, Lenvima, REBLOZYL, Epclusa, IMFINZI, BRAFTOVI.

Industry payments across CA — which companies pay providers there.